查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1614201

基於能量的治療市場：按產品類型、臨床應用和最終用戶分類 - 全球預測 2025-2030

Energy-Based Therapeutics Market by Product Type (Cryotherapy, Hydro-Mechanical, Microwave), Clinical Application (Aesthetic, Surgical & Ophthalmic), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年能量療法市場規模為68億美元，預計2024年將達72.8億美元，複合年成長率為7.36%，到2030年將達到111.9億美元。

以能量為基礎的療法是醫療保健領域一個不斷發展的領域，它利用各種形式的能量來治療醫療狀況並提供傳統藥物療法的替代治療方法。該領域包括雷射、射頻、超音波和微波等能量，每種能量應用於目標組織以產生治療效果，例如消融組織、促進癒合以及減輕疼痛和發炎。對基於能量的療法的需求在於其微創性質，與傳統手術方法相比，它通常可以實現更快的恢復時間、更低的感染風險以及更少的疤痕。這些治療方法應用於廣泛的領域，包括皮膚病學、腫瘤學、循環系統和整形外科。最終用途多種多樣，包括醫院、專科診所和門診手術中心。

主要市場統計
基準年[2023] 68億美元
預計年份 [2024] 72.8億美元
預測年份 [2030] 111.9億美元
複合年成長率（%） 7.36%

市場洞察表明，慢性病盛行率上升、技術進步以及消費者對微創手術的需求不斷增加是影響該行業成長的關鍵驅動力。此外，人口老化正在推動需求，因為與老齡化相關的疾病往往需要創新的治療方法。最新的機會是基於能量的療法在新興市場的廣泛應用。抓住這些機會的建議包括投資於研究和開發，以擴大能源技術的治療應用，並擴大策略夥伴關係，以促進進入新興市場。

然而，市場成長受到高治療成本、監管障礙以及從業者和患者意識有限的限制。挑戰還包括需要嚴格的臨床試驗來證明療效和安全性，這可能會延遲監管核准和市場准入。最佳創新領域包括提高設備的便攜性和能源效率，以及開發結合多種能源模式以提高治療效果的混合系統。隨著市場競爭的激烈，企業應專注於持續創新、策略聯盟和教育舉措，以克服障礙並利用新趨勢。

市場動態：揭示快速發展的能源治療市場的關鍵市場洞察

供需的動態交互作用正在改變基於能量的治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 世界各地人口老化不斷加劇，癌症等慢性病發生率不斷上升。
    • 與傳統手術和治療相比，微波消融系統越來越受歡迎。
  • 市場限制因素
    • 產品召回頻率增加
  • 市場機會
    • 基於能量的療法的創新和發展
    • 能源療法的政府舉措和有利的報銷政策
  • 市場挑戰
    • 認知低、缺乏熟練的人力資源和治療挑戰

波特五力：駕馭能源治療市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解對基於能量的治療市場的外部影響

外部宏觀環境因素在塑造能量治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解能量療法市場的競爭格局

基於能量的治療市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣能量治療市場供應商的績效評估

FPNV定位矩陣是評估能量療法市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了能源治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，基於能量的治療市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球老年人口不斷增加，癌症等慢性疾病的發生率也正在上升。
      • 微波消融系統比傳統手術和治療更受歡迎
    • 抑制因素
      • 產品召回頻率增加
    • 機會
      • 基於能量的療法的創新和發展
      • 能源療法的政府措施和有利的報銷政策
    • 任務
      • 缺乏意識和熟練人員以及治療挑戰
  • 市場區隔分析
    • 產品類型：擴大使用熱療和超音波療法治療深部病變
    • 臨床應用：採用能量為基礎的療法進行美容應用
    • 最終使用者：能量療法專科診所的出現
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章以能量為基礎的治療市場：依產品類型

  • 冷凍療法
  • 液壓機械
  • 微波爐
  • 無線電頻率
  • 熱和超音波

第7章臨床應用的能量治療市場

  • 美學的
  • 外科/眼科

第8章基於能量的治療市場：按最終用戶分類

  • 診所
  • 醫院

第9章美洲能源治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太能源治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的能量治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Baird Medical 的微波消融系統獲得 FDA 510(k) 許可
    • Oculus 推出 IPL、高頻治療設備
    • Emlation 在中東推出快速微波治療
  • 戰略分析和建議

公司名單

  • Alcon Vision LLC
  • Alna-Medicalsystem AG
  • AngioDynamics
  • AtriCure, Inc.
  • BIOLASE, Inc.
  • Biolitec AG
  • Boston Scientific Corporation
  • Bovie Medical Corporation
  • Candela Corporation by Syneron Medical Ltd.
  • Cutera, Inc.
  • Cynosure Inc.
  • Dornier MedTech GmbH
  • EDAP TMS SA
  • Ellex Medical Lasers
  • InSightec Ltd.
  • IRIDEX Corporation
  • Johnson and Johnson Vision Care Inc
  • LightMed Corporation
  • Lumenis Ltd.
  • Medtronic plc
  • NIDEk CO. LTD
  • Optos plc
  • PhotoMedex, Inc.
  • Symmetry Surgical Inc.
  • Ziemer Ophthalmic Systems AG
Product Code: MRR-BB4648AFF39A

The Energy-Based Therapeutics Market was valued at USD 6.80 billion in 2023, expected to reach USD 7.28 billion in 2024, and is projected to grow at a CAGR of 7.36%, to USD 11.19 billion by 2030.

Energy-based therapeutics is an evolving field within healthcare that harnesses various forms of energy to treat medical conditions, offering an alternative to traditional drug-based therapies. The scope of this field includes modalities like laser, radiofrequency, ultrasound, and microwave energy, each applied to target tissues for therapeutic effects such as tissue ablation, promotion of healing, or reduction of pain and inflammation. The necessity of energy-based therapeutics lies in its minimally invasive nature, which often enables quicker recovery times, reduced infection risks, and less scarring compared to traditional surgical techniques. These therapies have broad applications in dermatology, oncology, cardiology, and orthopedics. The end-use scope spans hospitals, specialty clinics, and ambulatory surgical centers.

KEY MARKET STATISTICS
Base Year [2023] USD 6.80 billion
Estimated Year [2024] USD 7.28 billion
Forecast Year [2030] USD 11.19 billion
CAGR (%) 7.36%

Market insights reveal that the rising prevalence of chronic diseases, advancements in technology, and increasing consumer demand for minimally invasive procedures are key drivers influencing growth in this sector. Additionally, demographic shifts towards an aging population fuel demand, as age-related conditions often necessitate innovative treatment methodologies. The latest opportunities involve expanding applications of energy-based therapeutics in emerging markets, driven by increased healthcare spending and improved access to healthcare technology. Recommendations for capturing these opportunities include investing in research and development to broaden the therapeutic indications of energy technologies and expanding strategic partnerships to facilitate market entry in developing regions.

However, market growth faces limitations such as high procedural costs, regulatory barriers, and limited awareness among practitioners and patients. Challenges also include the need for rigorous clinical trials to demonstrate efficacy and safety, which can delay regulatory approvals and market entry. The best areas for innovation include improving device portability and energy efficiency and developing hybrid systems that combine multiple energy modalities for enhanced therapeutic outcomes. As the market nature is highly competitive, businesses should focus on continuous innovation, strategic collaborations, and educational initiatives to overcome barriers and capitalize on emerging trends.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Energy-Based Therapeutics Market

The Energy-Based Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • The increasing geriatric population across the world, coupled with rising incidences of chronic diseases such as cancer
    • The surge in popularity of microwave ablation systems over conventional surgeries and treatment
  • Market Restraints
    • Increasing frequency of product recalls
  • Market Opportunities
    • Technological innovations and developments in energy-based therapeutics
    • Government initiatives and favorable reimbursement policies for energy-based therapeutics
  • Market Challenges
    • The dearth of awareness and skilled manpower and therapeutic challenges

Porter's Five Forces: A Strategic Tool for Navigating the Energy-Based Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Energy-Based Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Energy-Based Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Energy-Based Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Energy-Based Therapeutics Market

A detailed market share analysis in the Energy-Based Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Energy-Based Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Energy-Based Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Energy-Based Therapeutics Market

A strategic analysis of the Energy-Based Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Energy-Based Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Alcon Vision LLC, Alna-Medicalsystem AG, AngioDynamics, AtriCure, Inc., BIOLASE, Inc., Biolitec AG, Boston Scientific Corporation, Bovie Medical Corporation, Candela Corporation by Syneron Medical Ltd., Cutera, Inc., Cynosure Inc., Dornier MedTech GmbH, EDAP TMS S.A., Ellex Medical Lasers, InSightec Ltd., IRIDEX Corporation, Johnson and Johnson Vision Care Inc, LightMed Corporation, Lumenis Ltd., Medtronic plc, NIDEk CO. LTD, Optos plc, PhotoMedex, Inc., Symmetry Surgical Inc., and Ziemer Ophthalmic Systems AG.

Market Segmentation & Coverage

This research report categorizes the Energy-Based Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Cryotherapy, Hydro-Mechanical, Microwave, Radiofrequency, and Thermal & Ultrasound.
  • Based on Clinical Application, market is studied across Aesthetic and Surgical & Ophthalmic.
  • Based on End-User, market is studied across Clinics and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. The increasing geriatric population across the world, coupled with rising incidences of chronic diseases such as cancer
      • 5.1.1.2. The surge in popularity of microwave ablation systems over conventional surgeries and treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Increasing frequency of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological innovations and developments in energy-based therapeutics
      • 5.1.3.2. Government initiatives and favorable reimbursement policies for energy-based therapeutics
    • 5.1.4. Challenges
      • 5.1.4.1. The dearth of awareness and skilled manpower and therapeutic challenges
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Growing use of thermal & ultrasound energy-based therapeutics to treat deep-seated lesions
    • 5.2.2. Clinical Application: Adoption of energy-based therapeutics in aesthetic application
    • 5.2.3. End-User: Emergence of a specialized clinic for energy-based therapeutics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Energy-Based Therapeutics Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cryotherapy
  • 6.3. Hydro-Mechanical
  • 6.4. Microwave
  • 6.5. Radiofrequency
  • 6.6. Thermal & Ultrasound

7. Energy-Based Therapeutics Market, by Clinical Application

  • 7.1. Introduction
  • 7.2. Aesthetic
  • 7.3. Surgical & Ophthalmic

8. Energy-Based Therapeutics Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospital

9. Americas Energy-Based Therapeutics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Energy-Based Therapeutics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Energy-Based Therapeutics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Baird Medical's Microwave Ablation System Gains FDA 510(k) Clearance
    • 12.3.2. Oculus launches IPL, Radiofrequency Therapy Devices
    • 12.3.3. Emblation Launches Swift Microwave Therapy in the Middle East
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alcon Vision LLC
  • 2. Alna-Medicalsystem AG
  • 3. AngioDynamics
  • 4. AtriCure, Inc.
  • 5. BIOLASE, Inc.
  • 6. Biolitec AG
  • 7. Boston Scientific Corporation
  • 8. Bovie Medical Corporation
  • 9. Candela Corporation by Syneron Medical Ltd.
  • 10. Cutera, Inc.
  • 11. Cynosure Inc.
  • 12. Dornier MedTech GmbH
  • 13. EDAP TMS S.A.
  • 14. Ellex Medical Lasers
  • 15. InSightec Ltd.
  • 16. IRIDEX Corporation
  • 17. Johnson and Johnson Vision Care Inc
  • 18. LightMed Corporation
  • 19. Lumenis Ltd.
  • 20. Medtronic plc
  • 21. NIDEk CO. LTD
  • 22. Optos plc
  • 23. PhotoMedex, Inc.
  • 24. Symmetry Surgical Inc.
  • 25. Ziemer Ophthalmic Systems AG

LIST OF FIGURES

  • FIGURE 1. ENERGY-BASED THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. ENERGY-BASED THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ENERGY-BASED THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ENERGY-BASED THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENERGY-BASED THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ENERGY-BASED THERAPEUTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CRYOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY HYDRO-MECHANICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY MICROWAVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY THERMAL & ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY AESTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY SURGICAL & OPHTHALMIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. ENERGY-BASED THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. ENERGY-BASED THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023